Literature DB >> 12826435

Genome-wide mapping of human loci for essential hypertension.

Mark Caulfield1, Patricia Munroe, Janine Pembroke, Nilesh Samani, Anna Dominiczak, Morris Brown, Nigel Benjamin, John Webster, Peter Ratcliffe, Suzanne O'Shea, Jeanette Papp, Elizabeth Taylor, Richard Dobson, Joanne Knight, Stephen Newhouse, Joel Hooper, Wai Lee, Nick Brain, David Clayton, G Mark Lathrop, Martin Farrall, John Connell.   

Abstract

BACKGROUND: Blood pressure may contribute to 50% of the global cardiovascular disease epidemic. By understanding the genes predisposing to common disorders such as human essential hypertension we may gain insights into novel pathophysiological mechanisms and potential therapeutic targets. In the Medical Research Council BRItish Genetics of HyperTension (BRIGHT) study, we aim to identify these genetic factors by scanning the human genome for susceptibility genes for essential hypertension. We describe the results of a genome scan for hypertension in a large white European population.
METHODS: We phenotyped 2010 affected sibling pairs drawn from 1599 severely hypertensive families, and completed a 10 centimorgan genome-wide scan. After rigorous quality control, we analysed the genotypic data by non-parametric linkage, which tests whether genes are shared in excess among the affected sibling pairs. Lod scores, calculated at regular points along each chromosome, were used to assess the support for linkage.
FINDINGS: Linkage analysis identified a principle locus on chromosome 6q, with a lod score of 3.21 that attained genome-wide significance (p=0.042). The inclusion of three further loci with lod scores higher than 1.57 (2q, 5q, and 9q) also show genome-wide significance (p=0.017) when assessed under a locus-counting analysis.
INTERPRETATION: These findings imply that human essential hypertension has an oligogenic element (a few genes may be involved in determination of the trait) possibly superimposed on more minor genetic effects, and that several genes may be tractable to a positional cloning strategy.

Entities:  

Mesh:

Year:  2003        PMID: 12826435     DOI: 10.1016/S0140-6736(03)13722-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  65 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  From gene function to improved health: genome research in the United Kingdom.

Authors:  George K Radda; Ian Viney
Journal:  J Mol Med (Berl)       Date:  2004-01-08       Impact factor: 4.599

Review 3.  Genetic epidemiological approaches in the study of risk factors for cardiovascular disease.

Authors:  Anastasia Iliadou; Harold Snieder
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension.

Authors:  P Hamet; E Merlo; O Seda; U Broeckel; J Tremblay; M Kaldunski; D Gaudet; G Bouchard; B Deslauriers; F Gagnon; G Antoniol; Z Pausová; M Labuda; M Jomphe; F Gossard; G Tremblay; R Kirova; P Tonellato; S N Orlov; J Pintos; J Platko; T J Hudson; J D Rioux; T A Kotchen; A W Cowley
Journal:  Am J Hum Genet       Date:  2005-03-30       Impact factor: 11.025

Review 5.  The effect of genotyping error in sib-pair genomewide linkage scans depends crucially upon the method of analysis.

Authors:  Kevin Walters
Journal:  J Hum Genet       Date:  2005-07-30       Impact factor: 3.172

6.  Hypertension and ethnic group.

Authors:  Morris J Brown
Journal:  BMJ       Date:  2006-04-08

Review 7.  Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation.

Authors:  Kenneth M Weiss
Journal:  Genetics       Date:  2008-08       Impact factor: 4.562

8.  Pharmacogenomics of antihypertensive drugs: past, present and future.

Authors:  Julie A Johnson
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

Review 9.  Genetic architecture of complex traits predisposing to nephropathy: hypertension.

Authors:  Steven C Hunt
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

10.  Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array.

Authors:  Siim Sõber; Elin Org; Katrin Kepp; Peeter Juhanson; Susana Eyheramendy; Christian Gieger; Peter Lichtner; Norman Klopp; Gudrun Veldre; Margus Viigimaa; Angela Döring; Margus Putku; Piret Kelgo; Sue Shaw-Hawkins; Philip Howard; Abiodun Onipinla; Richard J Dobson; Stephen J Newhouse; Morris Brown; Anna Dominiczak; John Connell; Nilesh Samani; Martin Farrall; Mark J Caulfield; Patricia B Munroe; Thomas Illig; H-Erich Wichmann; Thomas Meitinger; Maris Laan
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.